Abstract
Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.
Original language | English (US) |
---|---|
Pages (from-to) | 922-924 |
Number of pages | 3 |
Journal | International journal of dermatology |
Volume | 43 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2004 |
ASJC Scopus subject areas
- Dermatology